Cetrelimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor, INHIBITOR of Programmed cell death protein 1 inhibitor

CAS: 2050478-92-5 Cat. No.: Ab179071
Disponible para pedir
CALIDAD & PUREZA Animal Free ? Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material. Carrier Free ? Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays. Recombinant ? Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin. ExactAb™ ? ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications. Low Endotoxin ? Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere. Azide Free ? Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. ≥95%(SDS-PAGE&SEC-HPLC) See COA
Application
Animal Model, ELISA, Flow Cytometry, Functional Assay
Host species
Humano
Reactive species
Humano, Mono cynomolgus
Isotype
Human IgG4SP
Conjugation
Unconjugated
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
100μg
Ab179071-100μg
—
Disponible ≥10
79,75€
1mg
Ab179071-1mg
—
4 Disponible
496,26€
5mg
Ab179071-5mg
—
1 Disponible
1.157,48€
10mg
Ab179071-10mg
Fabricado bajo pedido · 8–12 semanas
1.855,14€
Enter a quantity for the sizes you want to add.

Descripción general

Cetrelimab (anti-PDCD1) is a humanized mAb targeting PD-1. Cetrelimab (anti-PDCD1) binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab (anti-PDCD1) stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Especificaciones

Product Name
Cetrelimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Sinónimos
CD279 antibody|CD279 antigen antibody|hPD 1 antibody|hPD l antibody|hPD-1 antibody|hSLE1 antibody|PD 1 antibody|PD-1 antibody|PD1 antibody|PDCD 1 antibody|PDCD1 antibody|Programmed cell death 1 antibody|Programmed cell death 1 protein antibody|Programmed cell death protein 1 antibody|Protein PD 1 antibody|Protein PD-1 antibody|SLEB2 antibody|Systemic lupus erythematosus susceptibility 2 antibody|CD279 antigen|CD279|hPD-1|PD1|PD-1|PDCD1|programmed cell death 1|programmed cell death protein 1|Protein PD-1|SLEB2|JNJ 63723283|JNJ 3283
Especificaciones y pureza
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Especies hospedadoras
Humano
Especificidad
PDCD1
Conjugación
Unconjugated
Grado
Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Tipo de acción
INHIBITOR
Mecanismo de acción
INHIBITOR of Programmed cell death protein 1 inhibitor
Isotipo
Human IgG4SP
Tipo de cadena ligera
kappa
SDS-PAGE
26.7 kDa (Light Chain) & 53.2 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions.
Método de purificación
Protein A purified
Pureza
>95%
Concentración
See COA
CAS
2050478-92-5
Product Line
Productos biológicos
Almacenamiento y envío
Forma
Liquid
Condiciones de almacenamiento de almacenamiento
Store at -80°C,Avoid repeated freezing and thawing
Enviado en
Dry ice packs + Cold packs
Estabilidad y almacenamiento
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Imágenes

Cetrelimab (anti-PDCD1) (Ab179071) - Flow Cytometry
Flow Cytometry analysis of 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated MOLT-4 cells (24h) labelling PDCD1 (red) with Cetrelimab (anti-PDCD1) (Ab179071). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.


Cetrelimab (anti-PDCD1) (Ab179071) - SEC
The purity of Cetrelimab (anti-PDCD1) (Ab179071) is more than 95% verified by HPLC.

Datos avanzados

Objetivos asociados (humanos)
PDCD1 Tclin Programmed cell death protein 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDCD1 Tclin Programmed cell death protein 1 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeFechaArticulo
ZJ24F1114049ZJ24F1114049Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F1114050ZJ24F1114050Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F1114051ZJ24F1114051Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F0404224ZJ24F0404224Certificate of AnalysisFeb 11, 2026 Ab179071
ZJ24F0404225ZJ24F0404225Certificate of AnalysisFeb 11, 2026 Ab179071
ZJ24F0404226ZJ24F0404226Certificate of AnalysisFeb 11, 2026 Ab179071
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Necesita ayuda para elegir la calidad?

Nuestra guía de selección de calidades cubre la pureza, el estado del estabilizador y la idoneidad de la aplicación para todas las variantes de nuestro catálogo.

Ver la guía de calidades Animal Free → Ver la guía de calidades Carrier Free → Ver la guía de calidades Recombinant → Ver la guía de calidades Validated → Ver la guía de calidades ExactAb™ → Ver la guía de calidades Low Endotoxin → Ver la guía de calidades Azide Free →

Artículos relacionados

Camrelizumab (anti-PD-1) - Anticuerpo primario, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Cemiplimab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4, Antibody of programmed cell death 1 (CD279)
Nivolumab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1/PD-1/CD279, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Pembrolizumab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Mouse Anti-Human IgM Antibody - Anticuerpo secundario, for ELISA various applications, from Human, generated in Mouse, IgG1
Mouse Anti-Human IgG H&L (HRP) - Anticuerpo secundario, for ELISA various applications, from Human, generated in Mouse, IgG1
Goat Anti-Human IgG H&L (HRP) - Anticuerpo secundario, for WB,ELISA,IHC various applications, from Human, generated in Goat, IgG
Mouse Anti-Human IgG Antibody - Anticuerpo secundario, for ELISA,CLIA various applications, from Human, generated in Rat, IgG1
Human IgG - Anticuerpo de control isotípico, for WB,CLIA,LF,EIA,PRTIA various applications, generated in Human, >95%, IgG
Spartalizumab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Penpulimab (anti-PDCD1) - Anticuerpo primario, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG1, Antibody of programmed cell death 1 (CD279)
Sintilimab (anti-PD-1) - Anticuerpo primario, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Dostarlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Pidilizumab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor
Retifanlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Zimberelimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Tislelizumab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Goat Anti-Human IgG Antibody - Anticuerpo secundario, ≥ 95%
Mouse Anti-Human IgA H&L Antibody - Anticuerpo secundario, Mouse IgG1
Goat Anti-Human IgG (HRP) - Anticuerpo secundario
Goat Anti-Human IgG (Biotin) - Anticuerpo secundario
PD1 Mouse mAb - Anticuerpo primario, specific to PD1, Mouse IgG1
Goat Anti-Human IgG (Cy5) - Anticuerpo secundario
Goat Anti-Human IgG (APC) - Anticuerpo secundario
Goat Anti-Human IgG (PE) - Anticuerpo secundario
Goat Anti-Human IgG (TRITC) - Anticuerpo secundario
Goat Anti-Human IgG (FITC) - Anticuerpo secundario
Serplulimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Mouse Anti-Human IgE epsilon chain Antibody - Anticuerpo secundario
Geptanolimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP
Goat Anti-Human IgG Fc Antibody - Anticuerpo secundario, Goat IgG
Budigalimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor
Sasanlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Balstilimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP-Opti, ANTAGONIST of Programmed cell death protein 1 antagonist
Pimivalimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Ezabenlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP
Toripalimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1, ANTAGONIST of Programmed cell death protein 1 antagonist
Human IgG2-Kappa - Anticuerpo de control isotípico, Human IgG2
Human IgG3-kappa - Anticuerpo de control isotípico, Human IgG3
Finotonlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
PD1 Mouse mAb (FITC) - Anticuerpo primario, specific to PD1, Mouse IgG1
PD1 Mouse mAb (PE) - Anticuerpo primario, specific to PD1, Mouse IgG1
PD1 Mouse mAb (APC) - Anticuerpo primario, specific to PD1, Mouse IgG1
PD1 Mouse mAb (Biotin) - Anticuerpo primario, specific to PD1, Mouse IgG1
Peresolimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1
Rosnilimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1
PD1/CD279 Mouse mAb - Anticuerpo primario, specific to PD1/CD279, Mouse IgG1
Human IgG1-kappa, anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD, Human IgG1
Human IgG4-kappa - Anticuerpo de control isotípico, IgG4
Goat Anti-Human IgG (AF647) - Anticuerpo secundario, IgG
Goat Anti-Human IgG (AF405) - Anticuerpo secundario, IgG
Human IgG (FITC) - Anticuerpo de control isotípico, IgG
Human IgG (APC) - Anticuerpo de control isotípico, IgG
Human IgG (PE) - Anticuerpo de control isotípico, IgG
Human IgG1(P331S/E430G)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(P331S/E430G)
Human IgG1(D265A/N297A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(D265A/N297A)
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K409R/E356D/M358L)
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(P329G/E356D/M358L)
Human IgG1(F405L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(F405L)
Human IgG1(N297Q)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297Q)
Human IgG (Biotin) - Anticuerpo de control isotípico, IgG
Human IgG1(N297S)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297S)
Human IgG1(E233A/L235A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(E233A/L235A)
Human IgG1(K214R/N297A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/N297A)
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/L234A/L235A)
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297A/E356D/M358L)
Human IgG1(L234F/L235E)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(L234F/L235E)
Human IgG1(D265A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(D265A)
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/L234F/L235E/P331S)
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/E356D/M358L)
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(L234A/L235A/G237A)
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(L234A/L235A/F405L)
Human IgG1(D270N)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(D270N)
Human IgG4(S228P)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG4(S228P)
Human IgG1(N297A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297A)
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG4(S228P/L235E/P329G)
Human IgG1-lambda1, anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD, Human IgG1
Human IgG1-lambda2, anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD, Human IgG1
Iparomlimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP
Prolgolimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG1
Nofazinlimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP
Rulonilimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG1
Goat Anti-Human IgG (AF555) - Anticuerpo secundario, IgG
Human IgG1-kappa (AF405), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Human IgG1-kappa (AF647), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Human IgG1-kappa (APC), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Human IgG1-kappa (Biotin), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Human IgG1-kappa (AF700), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Human IgG1-kappa (FITC), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Human IgG1-kappa (AF555), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD
Centrose patent anti-dysadherin (anti-Dysadherin) - Anticuerpo primario, specific to FXYD5
Human IgG (AF647) - Anticuerpo de control isotípico
Human IgG (AF488) - Anticuerpo de control isotípico
Human IgG (AF700) - Anticuerpo de control isotípico
Human IgG (AF405) - Anticuerpo de control isotípico
Goat Anti-Human IgG (AF488) - Anticuerpo secundario
Goat Anti-Human IgG Fc (Cy5) - Anticuerpo secundario
Goat Anti-Human IgG Fc (AF555) - Anticuerpo secundario, specific to Human IgG Fc
Goat Anti-Human IgG Fc (TRITC) - Anticuerpo secundario
Goat Anti-Human IgG Fc (AF700) - Anticuerpo secundario, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF405) - Anticuerpo secundario
Goat Anti-Human IgG Fc (Biotin) - Anticuerpo secundario, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF647) - Anticuerpo secundario
Goat Anti-Human IgG Fc (FITC) - Anticuerpo secundario, specific to Human IgG Fc
Human IgG (AF555) - Anticuerpo de control isotípico

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.